Infectious Diseases News and Research

RSS

Global research network needed if scientists are ever going to understand and prevent cleft palate

Professor Bill Shaw, of The University of Manchester, says the complexity of craniofacial anomalies, like cleft lip and palate, means no one country, let alone institution, has the necessary expertise and resources to find all the answers to these distressing conditions.

From The University of Manchester 11 May 2005

Asymptomatic HIV-infected newborns may benefit from early drug treatment

Identifying and treating HIV-infected newborns is a race against the clock, according to a study from the Stanford University School of Medicine and Lucile Packard Children's Hospital.

10 May 2005

Fragile US vaccine system needs improvement

A comprehensive system of vaccine development in the U.S. resulted in a reduction of 87 to more than 99 percent in illness from ten vaccine-preventable diseases during the twentieth century. These dramatic successes should not be taken for granted, however, as the vaccine system now faces numerous challenges in manufacturing and development, according to a review article in the May/June issue of Health Affairs.

10 May 2005

Expert analyzes why manufacturers have gradually abandoned vaccines

Recent shortages of vaccines, most recently the flu vaccine during the past winter, are not short-term glitches--they reflect long-term problems in the vaccine industry. A variety of social, legal and economic forces have caused pharmaceutical companies to withdraw their commitment to vaccines, according to pediatrician and vaccine expert Paul A. Offit, M.D., chief of Infectious Diseases at The Children's Hospital of Philadelphia.

10 May 2005

Researchers test vaccine to prevent dangerous Staphylococcal infections

Vanderbilt University Medical Center infectious diseases researchers are launching a trial for a new vaccine against Staphylococcus aureus. The vaccine, if proven effective, could help curb the growing threat of methicillin-resistant Staphylococcus aureus (MRSA), an emerging organism rapidly spreading through close personal contact.

10 May 2005

As science gets wiser, so do the bugs

As science gets wiser, so do the bugs. The rates of drug-resistant bacteria infecting patients in the community and in the hospital have been increasing steadily in recent years, according to two new studies in the June 15 issue of Clinical Infectious Diseases.

9 May 2005

FDA seeks to ban gay men from donating sperm

The Food and Drug Administration (FDA), to the dismay of gay-rights activists, is recommending that any man who has had sex with another man in the previous five years be barred from serving as an anonymous sperm donor.

8 May 2005

Neutrophils dictate whether our immune system will permit or prevent bacterial infections

New research on a bacterium that can survive encounters with specific immune system cells has strengthened scientists' belief that these plentiful white blood cells, known as neutrophils, dictate whether our immune system will permit or prevent bacterial infections.

5 May 2005

Vaccine developed at Rockefeller University boosts natural killer T cells in patients with cancer

A new vaccine designed at The Rockefeller University boosted a type of fast-responding immune system cell called the natural killer T (NKT) cell in patients with advanced cancer. The study surprised researchers by revealing the ability of these NKT cells to spur other, slower-responding immune cells to go to work.

4 May 2005

Polio alert after Indonesian child is stricken

After an 18-month-old boy was diagnosed with polio, Australian parents planning holidays in Indonesia have been warned to ensure babies and toddlers have been vaccinated for polio.

3 May 2005

Too early to say if Roll Back Malaria initiative is working

Experts say it is too early to assess if an international initiative, Roll Back Malaria (RBM), has had any impact on combating malaria.

3 May 2005

Burden of cardiovascular disease will shift to the developing world

In a paper published this week in the premier open-access global health journal PLoS Medicine, Majid Ezzati and colleagues from Harvard School of Public Health conclude that a large proportion of the world's population who live in low-income and middle-income countries should be the focus for intervention against risk factors for cardiovascular disease because major cardiovascular risk factors will increasingly be concentrated in these populations.

3 May 2005

Intriguing new data on the spread of the Lyme disease bacteria through the blood stream

The ability to find the Lyme spirochete--the tick-borne agent responsible--in the blood is itself an achievement because existing methods of culturing blood were not sensitive enough to detect its presence until College researchers developed a new technique, which they used in the study.

2 May 2005

E. coli poses significant public health threat to seniors in the U.S.

A new study finds that E. coli bacteremia - a potentially life-threatening bloodstream infection caused by a common bacteria also associated with less dangerous urinary tract infections - poses a significant public health threat in the United States, especially among seniors.

2 May 2005

HIV treatment not affected by hormonal birth control

Estrogen and progesterone hormones in birth control do not influence the effectiveness of highly active antiretroviral therapy (HAART), which is used to treat HIV infection, according to researchers from the Johns Hopkins Bloomberg School of Public Health and other institutions. The study is published in the May 1, 2005, issue of the American Journal of Epidemiology.

2 May 2005

19 primary schoolchildren on HIV drugs after prank with needle

After an 8-year-old girl pricked her schoolmates with her mother's diabetes-testing needle nineteen primary school students have had to be been placed on drugs to fight HIV because one child in a group of nineteen was discovered to be HIV positive.

1 May 2005

Researchers show protein's role in stopping bacterial-induced inflammation

In findings that could have implications for autoimmune disorders and drug-resistant bacterial infections, researchers at the University of California, San Diego (UCSD) School of Medicine have identified a key protein involved in the appropriate shut-down of inflammation following an immune response to invading pathogens.

28 Apr 2005